Safety and Efficacy of the Subclavian Approach for Transcatheter Aortic Valve Implantation With the Core Valve Revalving System.

The article discusses a research study on the subclavian approach for transcatheter aortic valve implantation (TAVI) and its safety and efficacy with CoreValue revalving system. Study subjects include 514 consecutive patients in Italian hospitals from 2007 - 2009 with the CoreValue bioprosthesis, 54 case of which used the subclavian approach and compared complications, comorbidites and mortality. Conclusions indicated safety of the subclavian approach for TAVI with low complication rates.